Researchers develop ‘on-demand’ whole tumor cell vaccine against cancer

Based on non-invasive, easy-to-manipulate near-infrared (NIR) laser irradiation, researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and the University of the Chinese Academy of Sciences (UCAS) have developed a flexible and potent design for “on-demand” whole tumor cell vaccine (TCV). The study was published in Nature Communications on July 26.